Implant-borne prosthetics sales will grow through 2036, led by bone level prosthetics at 52.6% of the product type segment in 2026, driven by established clinical adoption and treatment protocol integration. The market was valued at USD 5.30 billion in 2025 and is expected to be worth USD 12.48 billion by 2036.